US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Saudi Arabia ETF

39.26

+0.23000.59%

Post-market: 39.260.00000.00%16:10 EDT

Volume:338.83K

Turnover:13.28M

Market Cap:647.79M

PE:0.04

High:39.31

Open:39.27

Low:39.08

Close:39.03

52wk High:41.50

52wk Low:35.81

Shares:16.50M

Float Shares:16.50M

Volume Ratio:1.19

T/O Rate:2.05%

Dividend:1.03

Dividend Rate:2.63%

EPS(TTM):883.82

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

OEM International Expands Finnish Footprint With Majority Stake in KSA Oy

Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/KSA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KSA\",,,,,undefined,":{"symbol":"KSA","market":"US","secType":"STK","nameCN":"iShares MSCI Saudi Arabia ETF","latestPrice":39.26,"timestamp":1787688000000,"preClose":39.03,"halted":0,"volume":338833,"hourTrading":{"tag":"盘后","latestPrice":39.26,"preClose":39.26,"latestTime":"16:10 EDT","volume":176,"amount":6909.759999999999,"timestamp":1787688605050,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005892902895208734,"floatShares":16500000,"shares":16500000,"eps":883.82,"marketStatus":"Post-Mkt","change":0.23,"latestTime":"08-25 19:22:13 EDT","open":39.27,"high":39.305,"low":39.08,"amount":13283287,"amplitude":0.005765,"askPrice":42.97,"askSize":100,"bidPrice":34.77,"bidSize":100,"shortable":3,"etf":1,"ttmEps":883.82,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":39.03,"sharesOutstanding":17700000,"nav":38.223369,"aum":630685588.5,"dividendRate":0.026347,"bidAskSpread":0.000355,"preHourTrading":{"tag":"盘前","latestPrice":39.9988,"preClose":39.03,"latestTime":"04:00 EDT","volume":1,"amount":39.9988,"timestamp":1787644802087,"change":0.9688,"changeRate":0.024822,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":39.26,"preClose":39.26,"latestTime":"16:10 EDT","volume":176,"amount":6909.759999999999,"timestamp":1787688605050,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.192615,"impliedVol":0.1794,"impliedVolPercentile":0.247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KSA\",,,,,undefined,":{"symbol":"KSA","floatShares":16500000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.192615,"shares":16500000,"dividePrice":1.0344,"high":39.305,"amplitude":0.005765,"preClose":39.03,"low":39.08,"week52Low":35.81,"pbRate":"--","week52High":41.5,"institutionHeld":0,"latestPrice":39.26,"eps":883.82,"divideRate":0.026347,"volume":338833,"delay":0,"ttmEps":883.82,"open":39.27,"prevYearClose":36.41,"prevWeekClose":38.31,"prevMonthClose":36.96,"prevQuarterClose":37.31,"fiveDayClose":38.06,"twentyDayClose":36.9,"sixtyDayClose":38.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KSA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"KSA","amount":0.593181,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares MSCI Saudi Arabia ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-22"},{"date":"2025-12-16","symbol":"KSA","amount":0.439514,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares MSCI Saudi Arabia ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-22","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-22"},{"date":"2025-06-16","symbol":"KSA","amount":0.633366,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares MSCI Saudi Arabia ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-23","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-23"},{"date":"2024-12-30","symbol":"KSA","amount":0.315306,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"iShares MSCI Saudi Arabia ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-03","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-03"},{"date":"2024-12-17","symbol":"KSA","amount":0.47595,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares MSCI Saudi Arabia ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KSA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.264645,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.259755,"currency":"USD"},{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.282101,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":0.44299,"currency":"USD"},{"executeDate":"2019-06-17","recordDate":"2019-06-18","paymentDate":"2019-06-21","value":0.300975,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KSA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KSA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635786946","title":"Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786946","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786946?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"- Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Officer - - First quarter sales of Symvess were $0.5 million in 2026 compared to $0.1 million in 2025 - ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293828/0/en/Humacyte-Announces-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4585","MAA","BK4167","KSA","AV","CTEV","BK4588","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633969366","title":"CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633969366","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633969366?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:30","pubTimestamp":1777926600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, May  04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first quarter reflec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3287176/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU0868494708.USD","LU2023250504.SGD","LU2264538146.SGD","AGT","BK4022","FXI","SCD","UAE","LU2357305700.SGD","IE00BD6J9T35.USD","BK4516","CAR","LU0251142724.SGD","LU0868494617.USD","BK4520","LU1861559042.SGD","KSA","IE00BSNM7G36.USD","BK4597","BK4139","BK4199","LU1988902786.USD","LU1064131342.USD","BK4230","LU1720051017.SGD","IND","BK4504","CAT","LU1974910355.USD","CRSP","LU0742534661.SGD","LU1548497426.USD","BK4611","LU2543165471.USD","LU0251131958.USD","LU1917777945.USD","LU1720051108.HKD","BK4556","ITP","LU2106854487.HKD","BK4077","SLE","LU1861558580.USD","LU0942090050.USD","LU0048573561.USD","BK4149","BK4532","LU0963586101.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823793","title":"Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823793","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823793?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609200,"startTime":"0","endTime":"0","summary":"- Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - - Purchase commitment received for a minimum of $1.475 million for a clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263668/0/en/Humacyte-Announces-Fourth-Quarter-and-Year-End-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0053671581.USD","BK4142","CTEV","IND","BK4167","MAA","BK4215","VAC","KSA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622053075","title":"OEM International Expands Finnish Footprint With Majority Stake in KSA Oy","url":"https://stock-news.laohu8.com/highlight/detail?id=2622053075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622053075?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:32","pubTimestamp":1774441948,"startTime":"0","endTime":"0","summary":"OEM International AB Class B ( ($SE:OEM.B) ) has issued an announcement. OEM International has agreed to acquire a majority stake in Kokkolan Sähkö...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oem-international-expands-finnish-footprint-with-majority-stake-in-ksa-oy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oem-international-expands-finnish-footprint-with-majority-stake-in-ksa-oy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861220207.SGD","LU0348788117.USD","BK4554","IE0034224299.USD","LU0072462343.USD","KSA","LU0823038988.USD","SG9999014484.SGD","LU1048588211.SGD","LU0516423174.USD","LU0048573645.USD","BK4551","LU0289960550.SGD","SG9999013486.USD","LU0516422440.USD","LU2065171311.SGD","LU1242518857.USD","LU2360107671.USD","SG9999006266.SGD","IE0031814969.USD","LU0589944569.HKD","LU0979878070.USD","SG9999002406.SGD","BK4085","LU2125910849.SGD","LU0499858602.USD","BK4220","LU0572940350.SGD","LU2125910500.SGD","SG9999013478.USD","BK4585","LU1861217088.USD","LU0345775950.USD","BK4548","LU2152927971.USD","SGXZ58947870.SGD","LU0175139822.USD","BK4503","LU2065170008.USD","SG9999002620.SGD","LU0823039010.USD","SG9999002604.SGD","LU0441851309.USD","SG9999005177.SGD","LU0572939691.SGD","LU0516422952.EUR","LU1242518931.SGD","BK4581","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620122869","title":"Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2620122869","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620122869?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:31","pubTimestamp":1773923460,"startTime":"0","endTime":"0","summary":"- Purchase commitment is for a minimum of $1.475 million of Symvess product -DURHAM, N.C., March  19, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3259008/0/en/Humacyte-Receives-Symvess-Purchase-Commitment-for-Clinical-Evaluation-and-Outreach-Program-in-the-Kingdom-of-Saudi-Arabia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KSA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":105,"code":"91000000","status":"200"}]}}